S Bhinder

My name is S. Bhinder, and I am the founder of Khabar 24x12, an independent digital news website dedicated to providing accurate, unbiased, and timely news. I have a strong interest in journalism and public awareness. Through Khabar 24x12, my aim is to cover national and international news, politics, sports, entertainment, business, and social issues. I focus on presenting facts in a clear and simple manner so readers can easily understand the news. I am committed to ethical journalism, transparency, and delivering trustworthy information to my audience.

Gt Vs Rcb: IPL Match Today, GT vs RCB: Predicted playing XI, head-to-head, pitch report, Ahmedabad weather update | Cricket News

AHMEDABAD: Six days after Royal Challengers Bengaluru chased down 206 at the M Chinnaswamy Stadium, Gujarat Titans face the defending champions again, this time at the Narendra Modi Stadium on Thursday, still looking for answers to familiar problems.GT have four wins and four losses from eight games but their mid-table position does not fully hide…

Read More

IPL 2026 | Vinod Kambli spotted at Wankhede Stadium amid health struggles; fans say ‘get well soon’ – WATCH | Cricket News

Vinod Kambli (Image credit: Instagram) NEW DELHI: Former India cricketer Vinod Kambli, despite struggling to walk and dealing with multiple health issues, was spotted outside the Wankhede Stadium following the IPL 2026 clash between Mumbai Indians and Sunrisers Hyderabad on Wednesday. Kambli was seen walking with the support of two men and was photographed by…

Read More

CUET UG 2026 city intimation slip released at cuet.nta.nic.in, admit cards to follow shortly for candidates

CUET UG 2026 city intimation slip released CUET UG 2026: The National Testing Agency has released the advance examination city intimation slip for candidates appearing in the Common University Entrance Test for undergraduate courses in 2026. The notification, issued on April 29, confirms that candidates can now access details of their allotted examination city through…

Read More

AbbVie’s patent on immunology therapy rejected

New Delhi: In good news for patients, Indian Patent Office has refused a patent on MNC firm AbbVie’s blockbuster immunology therapy Rinvoq, paving the way for affordable versions to enter the domestic market. In a recent hearing, the Delhi Patent Office held that the claimed invention was “obvious” and lacked inventive step, a violation of…

Read More